Novel functional risk factors for the prediction of cardiovascular events in vulnerable patients following acute coronary syndrome

Martin K. Reriani, Andreas J. Flammer, Abdi Jama, Lilach O Lerman, Amir Lerman

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Over the years there has been considerable improvement in the clinical outcomes of patients treated for acute coronary syndrome (ACS). Despite a significant reduction in acute mortality, a large percentage of patients post ACS continue to experience adverse cardiovascular (CV) events, with high long-term mortality rates and overall suboptimal medical management. Long-term risk prediction tools rely on traditional CV risk factors and are developed and validated in specific populations. Established CV risk factors, however, only explain half or fewer of CV events. These risk models may thus not be optimal in determining individual risk for long-term adverse outcomes or in helping to identify individual patients who do not respond to therapy. Identifying the specific plaque characteristics associated with increased likelihood for thrombotic complications and rapid progression has led to the concept of the vulnerable plaque. Recently, "vulnerable myocardium" (ie, myocardium that is prone to myocardial ischemia and fatal arrhythmia) has been shown to play an important role in outcome. Both vulnerable plaque and vulnerable myocardium are associated with functional vascular abnormalities, such as endothelial dysfunction, which are considered a key event in the initiation, progression and complications of coronary artery disease. Endothelial dysfunction may serve as an underlying unifying mechanism that would independently predict long-term outcome in patients with ACS undergoing revascularization.

Original languageEnglish (US)
Pages (from-to)778-783
Number of pages6
JournalCirculation Journal
Volume76
Issue number4
DOIs
StatePublished - 2012

Fingerprint

Acute Coronary Syndrome
Myocardium
Mortality
Myocardial Ischemia
Blood Vessels
Cardiac Arrhythmias
Coronary Artery Disease
Population
Therapeutics

Keywords

  • Acute coronary syndrome
  • Endothelial dysfunction
  • Endothelium
  • Therapeutic endpoint
  • Vascular health

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Novel functional risk factors for the prediction of cardiovascular events in vulnerable patients following acute coronary syndrome. / Reriani, Martin K.; Flammer, Andreas J.; Jama, Abdi; Lerman, Lilach O; Lerman, Amir.

In: Circulation Journal, Vol. 76, No. 4, 2012, p. 778-783.

Research output: Contribution to journalArticle

@article{d61c0356a27247c0897d5671b8918d20,
title = "Novel functional risk factors for the prediction of cardiovascular events in vulnerable patients following acute coronary syndrome",
abstract = "Over the years there has been considerable improvement in the clinical outcomes of patients treated for acute coronary syndrome (ACS). Despite a significant reduction in acute mortality, a large percentage of patients post ACS continue to experience adverse cardiovascular (CV) events, with high long-term mortality rates and overall suboptimal medical management. Long-term risk prediction tools rely on traditional CV risk factors and are developed and validated in specific populations. Established CV risk factors, however, only explain half or fewer of CV events. These risk models may thus not be optimal in determining individual risk for long-term adverse outcomes or in helping to identify individual patients who do not respond to therapy. Identifying the specific plaque characteristics associated with increased likelihood for thrombotic complications and rapid progression has led to the concept of the vulnerable plaque. Recently, {"}vulnerable myocardium{"} (ie, myocardium that is prone to myocardial ischemia and fatal arrhythmia) has been shown to play an important role in outcome. Both vulnerable plaque and vulnerable myocardium are associated with functional vascular abnormalities, such as endothelial dysfunction, which are considered a key event in the initiation, progression and complications of coronary artery disease. Endothelial dysfunction may serve as an underlying unifying mechanism that would independently predict long-term outcome in patients with ACS undergoing revascularization.",
keywords = "Acute coronary syndrome, Endothelial dysfunction, Endothelium, Therapeutic endpoint, Vascular health",
author = "Reriani, {Martin K.} and Flammer, {Andreas J.} and Abdi Jama and Lerman, {Lilach O} and Amir Lerman",
year = "2012",
doi = "10.1253/circj.CJ-12-0248",
language = "English (US)",
volume = "76",
pages = "778--783",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "4",

}

TY - JOUR

T1 - Novel functional risk factors for the prediction of cardiovascular events in vulnerable patients following acute coronary syndrome

AU - Reriani, Martin K.

AU - Flammer, Andreas J.

AU - Jama, Abdi

AU - Lerman, Lilach O

AU - Lerman, Amir

PY - 2012

Y1 - 2012

N2 - Over the years there has been considerable improvement in the clinical outcomes of patients treated for acute coronary syndrome (ACS). Despite a significant reduction in acute mortality, a large percentage of patients post ACS continue to experience adverse cardiovascular (CV) events, with high long-term mortality rates and overall suboptimal medical management. Long-term risk prediction tools rely on traditional CV risk factors and are developed and validated in specific populations. Established CV risk factors, however, only explain half or fewer of CV events. These risk models may thus not be optimal in determining individual risk for long-term adverse outcomes or in helping to identify individual patients who do not respond to therapy. Identifying the specific plaque characteristics associated with increased likelihood for thrombotic complications and rapid progression has led to the concept of the vulnerable plaque. Recently, "vulnerable myocardium" (ie, myocardium that is prone to myocardial ischemia and fatal arrhythmia) has been shown to play an important role in outcome. Both vulnerable plaque and vulnerable myocardium are associated with functional vascular abnormalities, such as endothelial dysfunction, which are considered a key event in the initiation, progression and complications of coronary artery disease. Endothelial dysfunction may serve as an underlying unifying mechanism that would independently predict long-term outcome in patients with ACS undergoing revascularization.

AB - Over the years there has been considerable improvement in the clinical outcomes of patients treated for acute coronary syndrome (ACS). Despite a significant reduction in acute mortality, a large percentage of patients post ACS continue to experience adverse cardiovascular (CV) events, with high long-term mortality rates and overall suboptimal medical management. Long-term risk prediction tools rely on traditional CV risk factors and are developed and validated in specific populations. Established CV risk factors, however, only explain half or fewer of CV events. These risk models may thus not be optimal in determining individual risk for long-term adverse outcomes or in helping to identify individual patients who do not respond to therapy. Identifying the specific plaque characteristics associated with increased likelihood for thrombotic complications and rapid progression has led to the concept of the vulnerable plaque. Recently, "vulnerable myocardium" (ie, myocardium that is prone to myocardial ischemia and fatal arrhythmia) has been shown to play an important role in outcome. Both vulnerable plaque and vulnerable myocardium are associated with functional vascular abnormalities, such as endothelial dysfunction, which are considered a key event in the initiation, progression and complications of coronary artery disease. Endothelial dysfunction may serve as an underlying unifying mechanism that would independently predict long-term outcome in patients with ACS undergoing revascularization.

KW - Acute coronary syndrome

KW - Endothelial dysfunction

KW - Endothelium

KW - Therapeutic endpoint

KW - Vascular health

UR - http://www.scopus.com/inward/record.url?scp=84858983984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858983984&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-12-0248

DO - 10.1253/circj.CJ-12-0248

M3 - Article

VL - 76

SP - 778

EP - 783

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 4

ER -